Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV

Curr Top Med Chem. 2021;21(6):461. doi: 10.2174/156802662106210304111713.

Author

Athina Geronikaki¹

Affiliation

¹ Member of Mediterranean And European Academies of Science and Arts School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.

PMID: 33849411
DOI: 10.2174/156802662106210304111713

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-Infective Agents / pharmacology*
Antitubercular Agents / pharmacology*
Antiviral Agents / pharmacology*
Drug Design
Drug Resistance, Microbial
Enzyme Inhibitors / pharmacology*
Humans
Molecular Docking Simulation
Protein Binding
SARS-CoV-2 / drug effects
Triazoles / chemistry
Tuberculosis / drug therapy

Substances

Anti-Infective Agents
Antitubercular Agents
Antiviral Agents
Enzyme Inhibitors
Triazoles